The synergistic activity of intra-amniotic prostaglandin F2 alpha and urea in the midtrimester elective abortion.
D000019:Abortifacient Agents; D000028:Abortion, Induced / Q000009:adverse effects / Q000379:methods*; D000293:Adolescent; D000328:Adult; D000650:Amnion; D001774:Blood Chemical Analysis; D001777:Blood Coagulation / Q000187:drug effects; D001806:Blood Urea Nitrogen; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004357:Drug Synergism; D004573:Electrolytes / Q000097:blood; D005260:Female; D005865:Gestational Age; D006801:Humans; D007267:Injections; D010121:Oxytocin; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects; D012965:Sodium Chloride / Q000009:adverse effects; D013997:Time Factors; D014508:Urea / Q000008:administration & dosage / Q000009:adverse effects
D000019:Abortifacient Agents; D004338:Drug Combinations; D004573:Electrolytes; D011453:Prostaglandins; D012965:Sodium Chloride; D010121:Oxytocin; D014508:Urea